Kezar Life Sciences reports positive Phase 2a data for zetomipzomib in autoimmune hepatitis, showing higher response rates and reduced steroid use.

Tenaya Therapeutics (NASDAQ: TNYA), and FirstSun Capital Bancorp (NASDAQ: FSUN) in March. These companies rank high, if not ...

Cibc World Markets Corp bought a new position in ADMA Biologics, Inc. (NASDAQ:ADMA – Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities and ...

The biotech stock's shares surged after Barron's said the market is underestimating potential sales of its Duchenne Muscular ...

Two auto-related stocks are up sharply after recommendations in Barron's. Plus: A little-known biotech soars 21% after a ...

We recently published a list of 10 Penny Stocks With Huge Upside Potential According To Analysts. In this article, we are ...

We recently published a list of 10 Penny Stocks With Huge Upside Potential According To Analysts. In this article, we are ...

Penny stocks trade below $5 and attract investors looking for high returns with a small initial investment. These stocks are often associated with small-cap and mid-cap companies, which have ...

Carnival Corporation (NYSE:CCL) shares are on the defensive Friday in the wake of positive FQ1 results, as broader market ...

Silexion Therapeutics (SLXN) announced it has completed an expanded development plan for its next-generation siRNA candidate, SIL204, which the ...

Facing geopolitical challenges, ZIM warns of a turbulent 2025 with weak growth and declining performance. Read more about ZIM ...

ADMA Biologics is Thursday's pick for IBD 50 Growth Stocks To Watch. ADMA stock is building a cup base as the biotech has the ...